Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
Condition: Pancreatic Ductal Adenocarcinoma Interventions: Radiation: Stereotactic body radiotherapy (SBRT); Drug: Zimberelimab; Drug: Quemliclustat; Drug: Etrumadenant; Drug: Modified FOLFIRINOX Sponsors: Gulam Manji; Arcus Biosciences, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials